Issuer Free Writing Prospectus

Filed Pursuant to Rule 433

Relating to the Preliminary Prospectus dated November 14, 2019

Registration Number 333-230982

GENPACT LUXEMBOURG S.À R.L.

GENPACT LIMITED

$400,000,000 3.375% Senior Notes due 2024

Pricing Term Sheet

November 14, 2019

The information in this pricing term sheet supplements the Company’s preliminary prospectus supplement, dated November 14, 2019 (the “Preliminary Prospectus Supplement”) and supersedes the information in the Preliminary Prospectus Supplement to the extent inconsistent with the information in the Preliminary Prospectus Supplement. This pricing term sheet is qualified in its entirety by reference to the Preliminary Prospectus Supplement. Terms used herein but not defined herein shall have the respective meanings as set forth in the Preliminary Prospectus Supplement.

 

Issuer:    Genpact Luxembourg S.à r.l.
Guarantor:    Genpact Limited
Expected Ratings (Moody’s / S&P)*:    Baa3 / BBB-
Security Title:    3.375% Senior Notes due 2024
Offering Format:    SEC registered
Pricing Date:    November 14, 2019
Settlement Date:    November 18, 2019 (T+2)
Maturity Date:    December 1, 2024
Interest Payment Dates:    June 1 and December 1, commencing June 1, 2020
Principal Amount:    $400,000,000
Benchmark Treasury:    UST 1.500% due October 31, 2024
Benchmark Treasury Price / Yield:    99-12 14 / 1.630%
Spread to Benchmark Treasury:    +175 bps
Yield to Maturity:    3.380%
Coupon:    3.375%
Public Offering Price:    99.976% of the principal amount, plus accrued interest, if any, from November 18, 2019
Optional Redemption Provisions:   

Make-Whole Call:

   Prior to November 1, 2024, T+30 bps

Par Call:

   On or after November 1, 2024
CUSIP / ISIN:    37254B AC4 / US37254BAC46


Joint Book-Running Managers:

 

  

Citigroup Global Markets Inc.

Morgan Stanley & Co. LLC

Wells Fargo Securities, LLC

BofA Securities, Inc.

Credit Agricole Securities (USA) Inc.

J.P. Morgan Securities LLC

*

Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

The issuer has filed a registration statement, including a prospectus and a preliminary prospectus supplement, with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus and the preliminary prospectus supplement in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and the preliminary prospectus supplement (or, if available, the prospectus supplement) if you request it by calling Citigroup Global Markets Inc. toll-free at 1-800-831-9146; Morgan Stanley & Co. LLC toll-free at 1-866-718-1649; or Wells Fargo Securities, LLC toll-free at 1-800-645-3751.

ANY DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL SYSTEM.

Genpact (NYSE:G)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Genpact Charts.
Genpact (NYSE:G)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Genpact Charts.